Utility of patient-derived xenografts to evaluate drug sensitivity and select optimal treatments for individual non-small-cell lung cancer patients
Xiaoqing Wang(Roche (China)), Lanxiang Wu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Yutang Huang(PharmacoGenetics (China)), Lingling Li(Guizhou Academy of Agricultural Sciences), Dan Chen(Jiangnan University), Qilin Zhao(Nanjing Tech University), Ju Zhu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Chunjie Wen(PharmacoGenetics (China))
Cited by 5
Related Papers
Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute
|Nature Protocols|2019|485
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade
|Cancer Discovery|2021|286
Single-cell and spatial transcriptome analysis reveals the cellular heterogeneity of liver metastatic colorectal cancer
|Science Advances|2023|220
In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target
|Cell|2021|200
Evaluation of lipid accumulation from lignocellulosic sugars by Mortierella isabellina for biodiesel production
|Bioresource Technology|2012|155